Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Journal of Pathology and Translational Medicine ; : 43-51, 2023.
Artículo en Inglés | WPRIM | ID: wpr-967638

RESUMEN

Traditionally, diagnostic pathology uses histology representing structural alterations in a disease’s cells and tissues. In many cases, however, it is supplemented by other morphology-based methods such as immunohistochemistry and fluorescent in situ hybridization. Single-cell RNA sequencing (scRNA-seq) is one of the strategies that may help tackle the heterogeneous cells in a disease, but it does not usually provide histologic information. Spatial sequencing is designed to assign cell types, subtypes, or states according to the mRNA expression on a histological section by RNA sequencing. It can provide mRNA expressions not only of diseased cells, such as cancer cells but also of stromal cells, such as immune cells, fibroblasts, and vascular cells. In this review, we studied current methods of spatial transcriptome sequencing based on their technical backgrounds, tissue preparation, and analytic procedures. With the pathology examples, useful recommendations for pathologists who are just getting started to use spatial sequencing analysis in research are provided here. In addition, leveraging spatial sequencing by integration with scRNA-seq is reviewed. With the advantages of simultaneous histologic and single-cell information, spatial sequencing may give a molecular basis for pathological diagnosis, improve our understanding of diseases, and have potential clinical applications in prognostics and diagnostic pathology.

2.
Journal of the Korean Neurological Association ; : 214-218, 2021.
Artículo en Coreano | WPRIM | ID: wpr-900896

RESUMEN

We report a 61-year-old woman with clinical course for Alzheimer’s disease (AD) dementia and discordant amyloid-β positron-emission tomography (PET) and cerebrospinal fluid biomarkers. Brain magnetic resonance imaging revealed remarkable atrophy in the hippocampus. However, repeated delayed 18F-flutemetamol brain amyloid PET images with 1 year-interval revealed no amyloid deposition, whereas her CSF revealed low Aβ42, high total tau and p-tau181. This discordant amyloid-β PET and CSF biomarkers in this early-onset AD dementia might be associated with her low resilience or mixed pathology.

3.
Journal of the Korean Neurological Association ; : 214-218, 2021.
Artículo en Coreano | WPRIM | ID: wpr-893192

RESUMEN

We report a 61-year-old woman with clinical course for Alzheimer’s disease (AD) dementia and discordant amyloid-β positron-emission tomography (PET) and cerebrospinal fluid biomarkers. Brain magnetic resonance imaging revealed remarkable atrophy in the hippocampus. However, repeated delayed 18F-flutemetamol brain amyloid PET images with 1 year-interval revealed no amyloid deposition, whereas her CSF revealed low Aβ42, high total tau and p-tau181. This discordant amyloid-β PET and CSF biomarkers in this early-onset AD dementia might be associated with her low resilience or mixed pathology.

5.
Annals of Dermatology ; : 478-480, 2018.
Artículo en Inglés | WPRIM | ID: wpr-716493

RESUMEN

No abstract available.


Asunto(s)
Humanos , Urticaria
6.
Annals of Dermatology ; : 483-485, 2018.
Artículo en Inglés | WPRIM | ID: wpr-716491

RESUMEN

No abstract available.


Asunto(s)
Síndrome de Schnitzler
7.
Allergy, Asthma & Immunology Research ; : 83-87, 2018.
Artículo en Inglés | WPRIM | ID: wpr-739384

RESUMEN

Knowledge of the clinical course of chronic spontaneous urticaria (CSU) remains unclear. The purpose of our study was to investigate the clinical course of CSU in the Korean adult population. Each patient in the CSU group who was defined by disease codes between 2003 and 2007 was tracked whether he or she went into remission or not until 2013. Kaplan-Meier survival analysis was carried out to analyze remission, and log-rank tests were performed for between-group comparisons. Demographic differences between subjects who went into remission 1 year after the initial diagnosis and those who did not were analyzed using χ² tests. A total of 13,969 subjects were included in the CSU group. The 1-, 2-, 3-, 4-, and 5-year remission rates of CSU were 21.5%, 33.0%, 38.9%, 42.6%, and 44.6%, respectively. The proportion of subjects in the 65+ age group (P=0.050) and with male gender (P=0.002) was significantly higher among subjects who did not go into remission 1 year after the initial diagnosis. Our study indicates that CSU could have a more persistent course than previously reported.


Asunto(s)
Adulto , Humanos , Masculino , Diagnóstico , Corea (Geográfico) , Urticaria
9.
Korean Journal of Dermatology ; : 407-409, 2018.
Artículo en Inglés | WPRIM | ID: wpr-715721

RESUMEN

No abstract available.


Asunto(s)
Papulosis Linfomatoide
10.
Annals of Dermatology ; : 378-379, 2018.
Artículo en Inglés | WPRIM | ID: wpr-715095

RESUMEN

No abstract available.


Asunto(s)
Escroto
11.
Allergy, Asthma & Immunology Research ; : 373-377, 2017.
Artículo en Inglés | WPRIM | ID: wpr-49028

RESUMEN

There was no previous population-based study on the comparison of the risk of chronic spontaneous urticaria (CSU) between autoimmune thyroid diseases (AITD) and age- and gender-matched controls. The primary objective of this study was to evaluate the risk of CSU after diagnosis of AITD using national registry data from Korea. The secondary objective was to evaluate other risk factors of CSU. Based on the disease code diagnoses in 2003-2005, we composed an AITD group (n=3,659) and an age- and gender-matched control group (n=18,295). Each patient was tracked for whether CSU occurs or not until 2013. After adjusting for demographic differences and comorbidities, patients with AITD had a significantly higher rate of CSU compared to the control group (hazard ratio [HR], 1.46; 95% confidence interval [CI], 1.25-1.70; P<0.001). Among the AITD patients, the adjusted HR for CSU was higher in patients with Hashimoto's thyroiditis (HR, 1.50) than in those with Grave's disease (HR, 1.33), although the difference was not statistically significant (P=0.368). Analysis of CSU patients associated with AITD showed that female patients had a significantly higher risk of CSU compared to male ones (HR, 1.34; P=0.001) and that those with allergic rhinitis (HR, 1.51; P<0.001), atopic dermatitis (HR, 2.44; P<0.001), and asthma (HR, 1.50; P<0.001) had a significantly higher risk of CSU compared to patients without respective diseases. Our results demonstrated that AITD could be significantly associated with an increased risk of CSU.


Asunto(s)
Femenino , Humanos , Masculino , Asma , Comorbilidad , Dermatitis Atópica , Diagnóstico , Enfermedad de Graves , Enfermedad de Hashimoto , Corea (Geográfico) , Rinitis Alérgica , Factores de Riesgo , Enfermedades de la Tiroides , Glándula Tiroides , Tiroiditis , Urticaria
12.
Annals of Dermatology ; : 383-384, 2017.
Artículo en Inglés | WPRIM | ID: wpr-153474

RESUMEN

No abstract available.


Asunto(s)
Colesterol , Granuloma
13.
Annals of Dermatology ; : 813-814, 2017.
Artículo en Inglés | WPRIM | ID: wpr-25207

RESUMEN

No abstract available.


Asunto(s)
Síndrome de Churg-Strauss , Eosinófilos , Eritema
15.
Korean Journal of Dermatology ; : 52-55, 2017.
Artículo en Coreano | WPRIM | ID: wpr-27293

RESUMEN

Androgenetic alopecia (AGA) is a common form of hair loss that usually occurs in the third or fourth decades of life in men, with later onset in women. AGA does rarely occur, however, in the pediatric population. Adolescent AGA is pattern hair loss occurring in boys and girls between 12 and 18 years of age. We herein report the case of a 16-year-old girl with a 5-year history of diffuse hair loss on the crown. Her father had a history of AGA, and the hair pull test was negative. Sex hormone levels and thyroid function test were within the normal range. Phototrichogram analysis revealed diffuse hair thinning over the frontal and vertex areas, and the percentage of vellus hair was higher on the vertex than the occiput. We diagnosed the patient with adolescent AGA. She was prescribed 3% topical minoxidil, and improvement was visible on the clinical photograph and phototrichogram after 2 years of treatment.


Asunto(s)
Adolescente , Femenino , Humanos , Masculino , Alopecia , Coronas , Padre , Cabello , Minoxidil , Valores de Referencia , Pruebas de Función de la Tiroides
16.
Natural Product Sciences ; : 35-39, 2017.
Artículo en Inglés | WPRIM | ID: wpr-198624

RESUMEN

D-chiro-inositol (DCI) is a secondary messenger in insulin signal transduction. It is produced in vivo from myo-inositol via action of epimerase. In this study, we evaluated antitumor activity of DCI against human breast cancer both in vitro and in vivo. In order to determine the inhibitory effects of DCI on growth of human breast cancer cells (MDA-MB-231), two different assessment methods were implemented: MTT assay and mouse xenograft assay. MTT assay demonstrated downturn in cell proliferation by DCI treatment (1, 5, 10, 20 and 40 mM) groups by 18.3% (p<0.05), 17.2% (p<0.05), 17.5% (p<0.05), 18.4% (p<0.05), and 24.9% (p<0.01), respectively. Also, inhibition of tumor growth was investigated in mouse xenograft model. DCI was administered orally at the dose of 500 mg/kg and 1000 mg/kg body weight to treat nude mouse for 45 consecutive days. On the 45th day, tumor growth of DCI (500 mg/kg and 1000 mg/kg) groups was suppressed by 22.1% and 67.6% as mean tumor volumes were 9313.8 ± 474.1 mm³ and 3879.1 ± 1044.1 mm³, respectively. Furthermore, breast cancer stem cell (fCSC) phenotype (CD44⁺/CD24⁻) was measured using flow cytometry. On the 46th day, CSC ratios of DCI (500 mg/kg) and co-treatment with doxorubicin (4 mg/kg) and DCI (500 mg/kg) group decreased by 24.7% and 53.9% (p<0.01), respectively. Finally, from tumor recurrence assay, delay of 5 days in the co-treatment group compared to doxorubicin (4 mg/kg) alone group was observed. Based on these findings, we propose that DCI holds potential as an anti-cancer drug for treatment of breast cancer.


Asunto(s)
Animales , Humanos , Ratones , Peso Corporal , Neoplasias de la Mama , Mama , Proliferación Celular , Doxorrubicina , Citometría de Flujo , Xenoinjertos , Técnicas In Vitro , Insulina , Ratones Desnudos , Células Madre Neoplásicas , Fenotipo , Recurrencia , Transducción de Señal , Células Madre
17.
Annals of Dermatology ; : 513-514, 2016.
Artículo en Inglés | WPRIM | ID: wpr-221594

RESUMEN

No abstract available.

18.
Annals of Dermatology ; : 395-397, 2016.
Artículo en Inglés | WPRIM | ID: wpr-80325

RESUMEN

No abstract available.


Asunto(s)
Artritis Reumatoide , Dermatitis
19.
Korean Journal of Dermatology ; : 230-231, 2016.
Artículo en Inglés | WPRIM | ID: wpr-62957

RESUMEN

No abstract available.


Asunto(s)
Cuerpos Extraños , Granuloma de Cuerpo Extraño , Mesoterapia
20.
Annals of Dermatology ; : 586-592, 2016.
Artículo en Inglés | WPRIM | ID: wpr-59030

RESUMEN

BACKGROUND: Microneedle is a method that creates transdermal microchannels across the stratum corneum barrier layer of skin. No previous study showed a therapeutic effect of microneedle itself on hair growth by wounding. OBJECTIVE: The aim of this study is to investigate the effect of repeated microwound formed by microneedle on hair growth and hair growth-related genes in a murine model. METHODS: A disk microneedle roller was applied to each group of mice five times a week for three weeks. First, to identify the optimal length and cycle, microneedles of lengths of 0.15 mm, 0.25 mm, 0.5 mm, and 1 mm and cycles of 3, 6, 10, and 13 cycles were applied. Second, the effect of hair growth and hair-growth-related genes such as Wnt3a, β-catenin, vascular endothelial growth factor (VEGF), and Wnt10b was observed using optimized microneedle. Outcomes were observed using visual inspection, real-time polymerase chain reaction, and immunohistochemistry. RESULTS: We found that the optimal length and cycle of microneedle treatment on hair growth was 0.25 mm/10 cycles and 0.5 mm/10 cycles. Repeated microneedle stimulation promoted hair growth, and it also induced the enhanced expression of Wnt3a, β-catenin, VEGF, and Wnt10b. CONCLUSION: Our study provides evidence that microneedle stimulation can induce hair growth via activation of the Wnt/β-catenin pathway and VEGF. Combined with the drug delivery effect, we believe that microneedle stimulation could lead to new approaches for alopecia.


Asunto(s)
Animales , Ratones , Alopecia , Folículo Piloso , Cabello , Inmunohistoquímica , Métodos , Reacción en Cadena en Tiempo Real de la Polimerasa , Piel , Factor A de Crecimiento Endotelial Vascular , Heridas y Lesiones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA